Drug profile · INN
ciprofloxacin
APO-CIPROFLOXACIN
ciprofloxacin (APO-CIPROFLOXACIN) is a bacterial dna gyrase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — ciprofloxacin
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 6
- Programs
- 24
- Data quality
- 0.89
Quick answer
ciprofloxacin (APO-CIPROFLOXACIN) is a bacterial dna gyrase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial DNA gyrase inhibitor
Primary target: Bacterial DNA gyrase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12097185
Compositions comprising ciprofloxacin and celecoxib
granted -
US 11369566
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
granted -
US 9603796
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
granted -
US 9233068
Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders
granted -
US 9205048
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
granted -
US 8318817
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
granted
Frequently asked questions
What is ciprofloxacin?
ciprofloxacin (APO-CIPROFLOXACIN) is a bacterial dna gyrase inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ciprofloxacin?
APO-CIPROFLOXACIN is a marketed brand name for ciprofloxacin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ciprofloxacin?
ciprofloxacin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.